Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,087 across all filing types
Latest filing 2023-07-04 Regulatory Filings
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealing disclosures of a person with interests in relevant securities representing 1% or more. This type of document is a specific regulatory requirement for major shareholders or entities involved in takeover situations and is filed via a Regulatory Information Service (RNS). It does not fit into categories like 'Major Shareholding Notification' (which usually refers to TR-1 filings) or 'Director's Dealing', but rather falls under the broader category of regulatory filings required by the Takeover Panel.
2023-07-04 English
Form 8.3 - Network International Holdings Plc
Regulatory Filings Classification · 100% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more. This type of disclosure is a specific regulatory requirement for market surveillance and does not fit into categories like Annual Reports, Earnings Releases, or M&A activity reports (though it relates to an offer, it is a disclosure of holdings, not the M&A document itself). Therefore, it is classified as a Regulatory Filing (RNS).
2023-07-03 English
Form 8.3 - Horizon Therapeutics PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used for 'Opening Position Disclosure/Dealing Disclosure' by persons with interests in relevant securities representing 1% or more during a takeover or merger situation. This falls under the category of 'Major Shareholding Notification' (MRQ) as it reports significant share ownership and changes in positions related to an offeror/offeree.
2023-07-03 English
Form-8.3--HORIZON THERAPEUTICS PLC
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is specifically used for 'Opening Position Disclosure/Dealing Disclosure' by persons with interests in relevant securities representing 1% or more during a takeover period. This type of filing is a regulatory requirement for major shareholders to disclose their positions and dealings in the context of an M&A transaction. Since it does not fit into the specific categories of M&A activity (which usually refers to the company's own announcements) or major shareholding notifications (which are typically broader), it falls under the 'Regulatory Filings' category as a standard disclosure document.
2023-06-30 English
Form 8.3 - NETWORK INTERNATIONAL HOLDINGS PLC
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details shareholdings, derivative positions, and recent dealings. Since this is a specific regulatory disclosure regarding major shareholding interests and market activity related to a takeover, it falls under the 'Major Shareholding Notification' category.
2023-06-30 English
Form-8.3--HORIZON THERAPEUTICS PLC
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in a company involved in a takeover (Horizon Therapeutics PLC). This type of disclosure is a specific regulatory requirement for M&A activity and does not fit into the other categories like 10-K, ER, or DIRS (which is for internal directors). Since it is a formal regulatory disclosure regarding takeover-related shareholdings, it is classified as a Regulatory Filing (RNS).
2023-06-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.